TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/21 20:58 | 11/18/21 | CRTX | Cortexyme, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lynch Casey | CA | DO | CEO | M.d | 28 | 0.4600 | 0 | 60 | 5 | 1,181 | D | ||||||||||||||
5/12/21 16:51 | 5/10/21 | CRTX | Cortexyme, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lynch Casey | CA | DO | CEO | S | -1,037 | 34.58 | 0 | -30 | -3 | 1,121 | I | ||||||||||||||
3/23/21 19:06 | 3/22/21 | CRTX | Cortexyme, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lynch Casey | CA | DO | CEO | S | -1,068 | 35.59 | 0 | -30 | -3 | 1,151 | I | ||||||||||||||
2/3/21 19:45 | 2/1/21 | CRTX | Cortexyme, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lynch Casey | CA | DO | CEO | S.m | -2,310 | 38.49 | 0 | -60 | -5 | 1,181 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |